LDF panel backed SMA generic drug; CPM opposes it now
Despite past Left agitations for cheap generic medicines, Kerala's expert committee delayed procuring Natco's affordable spinal muscular atrophy drug, instead favoring Roche's expensive alternative amid external pressure and pending regulatory clarification.
Read the full report on Onmanorama
Story file
- Section
- India
- Places
- Kerala
- First reported by
- Onmanorama
- Reporter
- manoj kadambad
- Published
- Saturday, 24 October 2026, 8:21 am IST
- Coverage
- One outlet so far
How this page works. The Headline Update lists this report from Onmanorama with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.
